about
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanomaDetection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device.Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles
P50
description
researcher ORCID ID = 0000-0001-8065-8416
@en
wetenschapper
@nl
name
James B Freeman
@ast
James B Freeman
@en
James B Freeman
@nl
type
label
James B Freeman
@ast
James B Freeman
@en
James B Freeman
@nl
prefLabel
James B Freeman
@ast
James B Freeman
@en
James B Freeman
@nl
P106
P21
P31
P496
0000-0001-8065-8416